Searched for
PHARMACEUTICAL MANUFACTURERS
India eyes $12 billion trade with Egypt, but exporters flag tariff and payment hurdlesFrom cotton yarn, pharmaceuticals and speciality chemicals to engineering goods, EV charging and digital infrastructure, Indian businesses ...
Govt proposes tighter scrutiny of antimicrobial drugs to address resistance worriesThe government is proposing amendments to the New Drugs and Clinical Trials Rules, 2019 for antimicrobial medicines. This amendment would r...
IPO-bound Aragen plans to spend Rs 1.5 billion over 2 years for expansion, MD saysAragen Life Sciences intends to invest about 1.5 billion rupees in expanding its drug development and manufacturing operations. The investm...
Piyush Goyal, Italy's Tajani seek stronger ties in autos, pharma and technologyIndia and Italy are fostering stronger economic ties through joint ventures and technology partnerships. They seek collaboration in sectors...
India can replicate pharma, IT success in emerging sectors to boost exports: EconomistNaina Lal Kidwai highlighted India's ability to expand its export successes in emerging industries like electronics and defense. She emphas...
For long-term investors, with some patience: 5 large-cap stocks from different sectors with upside potential of up to 24%There comes a point in the stock market when it is more important to manage risk than to take it. It is a lesson that is often forgotten wh...
Drug regulator seeks pre-1988 approval records to compile national list of medicinesThe Indian government has initiated a process to create a consolidated list of approved drugs for regulatory purposes. This list will inclu...
India needs policy predictability to speed up drug approvals and boost pharma innovation: OPPI DGAnil Matai from the Organisation of Pharmaceutical Producers of India emphasized the need for regulatory predictability. He noted that Indi...
Breckenridge Pharmaceutical recalls blood pressure medicine Propranolol: Lot number, expiration date, health risks and what you should do nowBreckenridge Pharmaceutical Propranolol recall explained: Breckenridge Pharmaceutical has recalled one lot of its 60 mg extended-release pr...
Govt says Xiaomi, Flextronics hid royalty deals in tariff fightThe Indian government has accused Xiaomi India and contract manufacturer Flex of failing to fully disclose royalty arrangements, as it seek...
As industry steps up activity, corporate borrowing followsCorporate loan demand is increasing as companies in various sectors seek financing to support growth. The Reserve Bank of India's survey sh...
PM in Manila: Aligning act east, Indo-Pacific & MAHASAGAR policiesPrime Minister Narendra Modi will visit Manila for the ASEAN Summit, focusing on strengthening India's partnerships. The growing competitio...
Goyal in Egypt: Both sides to discuss increasing cooperation in infra, mnfg, logisticsCommerce and Industry Minister Piyush Goyal will visit Egypt for two days to enhance trade relations. He will engage in discussions to faci...
Compulsory licensing of drugs only after exhausting all other measures: Department of Pharmaceuticals secretary Manoj JoshiThe government plans to address the high costs of innovative medicines by first negotiating prices. Compulsory licensing will be considered...
Blue Jet Healthcare evaluating Rs 500 crore investment in Andhra Pradesh API manufacturing facilityBlue Jet Healthcare is evaluating the acquisition of 50 acres of land in Andhra Pradesh for an API manufacturing facility. The company plan...
NPPA issues strict guidelines for trade margin rationalisation on 137 cancer drugs to benefit patientsThe National Pharmaceutical Pricing Authority has implemented strict monitoring of Trade Margin Rationalisation for certain anti-cancer dru...
PLI schemes achieve 76% of investment target, 64% of production goal: Niti AayogThe production-linked incentive (PLI) scheme has achieved 76% of its investment target and 64% of its production target, with electronics, ...
India may open doors to multinational pharma firms for first-in-human Phase I trialsIndia is considering modifications to its pharmaceutical regulatory framework to attract multinational companies for clinical trials. Discu...
Government extends ₹2,700-crore PLI scheme for medical devices till 2035-36, eases eligibility normsThe government has extended the ₹2,700-crore production-linked incentive (PLI) scheme for domestic medical device manufacturing until 2035-...
Pharma industry steps up API investments to cut import dependence, move up value chainIndia's pharmaceutical sector is shifting towards high-value medicines and reducing reliance on imports through local manufacturing. Invest...